Home › Pulmonary Hypertension › Florida › Orlando
Pulmonary Hypertension clinical trials in Orlando, FL
5 studies for Pulmonary Hypertension are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
RecruitingPhase 3
- Clinical Research Site, Kissimmee · 16 mi away
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- AdventHealth Orlando, Orlando
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecruitingPhase 2
- Clinical Research Site, Kissimmee · 16 mi away
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Advent Health Medical Group Advanced Lung Disease, Orlando
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
RecruitingObservational study
- Advent Health, Orlando
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Phoenix, AZ9 studies
- Aurora, CO9 studies
- New York City, NY8 studies
- Kansas City, KS8 studies
- Cincinnati, OH8 studies
- Boston, MA8 studies
- Indianapolis, IN8 studies
- Bend, OR7 studies
- Salt Lake City, UT7 studies
- Houston, TX7 studies
- Rochester, MN7 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer44 studies
- Obesity31 studies
- Metastatic Cancer29 studies
- Overweight27 studies
- Alzheimer's Disease25 studies
- Type 2 Diabetes24 studies
- Cancer (all types)24 studies
- Breast Cancer23 studies
- Ovarian Cancer22 studies
- Ulcerative Colitis22 studies
- Lung Cancer21 studies
- Colorectal Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.